Dr. Mohammad Sabbagh, MD

Dr. Sabbagh practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Sabbagh's NPI, 1568860922, was assigned on December 16, 2014. Dr. Sabbagh holds Michigan license 4301116902.

Dr. Sabbagh's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Sabbagh's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Sabbagh is also affiliated with Corewell Health Dearborn Hospital. The medical group on file is Dr. Ghassan A. Atto, M.D. Dmand AI also links Dr. Sabbagh to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sabbagh practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sabbagh's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sabbagh is licensed in Michigan.

CMS data shows 408 Medicare services from Dr. Sabbagh across 5 procedure codes in 2024, for 91 Medicare patients. Medicare paid $30,886 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Sabbagh in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sabbagh's median patient age at 45, with 55% women.

In 2024, Dr. Sabbagh wrote 1,331 Medicare Part D claims for 177 patients. 79% of them were for generic drugs. CMS names the drug for 808 of them, across 35 drugs with 11 or more claims each, at $121,579 in total drug cost. In 2023, CMS named 1,729 claims across 56 drugs.

Dr. Sabbagh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sabbagh as offering telehealth.

CMS Open Payments shows 57 general payments to Dr. Sabbagh from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $493.